News

Unifying the management of clinical research documentation and marketing content saves time and accelerates speed-to-therapy

GDP standards drive higher performance standards for packaging

Manufacturers will need to refine their interactions with healthcare providers and produce better outcomes research and adherence programs to compete

Pharmaceutical Commerce's annual Cold Chain Sourcebook projects 44% growth over the 2013-2019 span

'Filgrastim-sndz' is Sandoz' Zarxio, the biosimilar of Amgen's Neuprogen

Success in managing DSCSA traceability requirements bring a $20-million equity investment

Reporting by pharma companies on spending on physicians is becoming a non-event

Last year's decision will cost US hospitals $300 million, says Novation-led group

Emphasis of 'physician preference items' in healthcare distribution

However, most payers will continue to adjust their drug coverage

Step-by-step process for addressing potential shortages is outlined

Identity Hub expedites access to regulated content in clinical research; now, prescribing and other commercial applications are being adopted

Collaboration with American College of Cardiology could result in new health-outcomes results

Nearly 100 cargo stations have been enhanced for pharma cold-chain distribution

First of what are expected to be many global 3PL sites, especially for specialty pharmaceuticals

$2-billion acquisition brings a $5-billion/yr PBM to Rite Aid's 4,600 retail stores

Service eases the management of domestic US shipments to trading partners and patients

Vaccine trials will continue without a clear path forward

KoolTemp GTS Instant avoids use--and cost--of refrigerants

Whole blood use is declining while plasma-derived product consumption rises

Annual specialty-distribution study focuses trend in oncology, chronic diseases

More executional capabilities derive from affiliation with parent, inVentiv Health

Company uses online media to promote fill rates by over 50%

$296-million bid makes it the 'stalking horse' buyer in Dendreon auction

Roughly 40% are for rare diseases; PD-1 oncolytics capture industry attention

Mapi Group casts itself as a leading 'health research and commercialization' player

'Stay tuned' for interactions directly with pharma companies, says CEO Jeff Tangney

So long WAG, hello to WBA as pharma manufacturers look at a consolidating buyer landscape